Comments on two recent papers dealing with the teratogenicity of medroxyprogesterone acetate.
Marks
T A
TA
D000014:Abnormalities, Drug-Induced; D000818:Animals; D003692:Delayed-Action Preparations; D005260:Female; D008525:Medroxyprogesterone / Q000031:analogs & derivatives* / Q000633:toxicity; D017258:Medroxyprogesterone Acetate; D051379:Mice; D011247:Pregnancy; D012107:Research Design
D003692:Delayed-Action Preparations; D017258:Medroxyprogesterone Acetate; D008525:Medroxyprogesterone